← Leaderboards
Michael Harrison Hsieh
Stanford University
$4,642,668
Attributed
$5,664,163
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $903.5K · FY2010–23$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,664,163 · 6
By mechanism
R01$3,062,234 · 2
R56$1,219,511 · 2
K08$902,360 · 1
R21$480,058 · 1
Top collaborators
- Jin U Kang3 shared
- Axel Krieger3 shared
- Vincent James Obias1 shared
Most similar at Stanford University
Same institution · by research overlap
- Thomas M. Krummel$3,047,856
- Dorsa Sadigh$2,720,622
- Maya J Benbarak$84,032
- Bruce Daniel$164,000
- Gunter Niemeyer$304,446
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseAffectGenitourinary SystemIncidenceGenesGenetic TranscriptionPropertyCytokineCellsPathway InteractionsUropathogenBiologyProductionViralLeadEpithelial CellsLigandsInfectionIn VivoEnvironmentChildhoodTrainingMediatingPathogen
Grant awards (19)
Next Generation Robotic System for Supervised-Autonomous Bowel Anastomosis$748,337
R56 · FY2023 · EB
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes$396,261
R01 · FY2021 · DK · contact PI
Developing a Next Generation Mouse Model of Urogenital Schistosomiasis Through Ultrasound-Guided Percutaneous Bladder Wall Injection of Schistosoma haematobium Eggs$178,500
R21 · FY2021 · AI · contact PI
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes$396,261
R01 · FY2020 · DK · contact PI
Developing a Next Generation Mouse Model of Urogenital Schistosomiasis Through Ultrasound-Guided Percutaneous Bladder Wall Injection of Schistosoma haematobium Eggs$301,558
R21 · FY2020 · AI · contact PI
Next Generation of Surgical Imaging and Robotics for Supervised Autonomous Soft Tissue Surgery$318,634
R01 · FY2019 · EB
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes$299,825
R01 · FY2019 · DK · contact PI
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes$231,816
R01 · FY2019 · DK · contact PI
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes$531,798
R01 · FY2018 · DK · contact PI
Next Generation of Surgical Imaging and Robotics for Supervised Autonomous Soft Tissue Surgery$371,729
R01 · FY2018 · EB
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes$515,910
R01 · FY2017 · DK · contact PI
Defining the Immunomodulatory Niche of Schistosoma haematobium IPSE$471,174
R56 · FY2015 · AI · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$143,195
K08 · FY2014 · DK · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$143,195
K08 · FY2014 · DK · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$153,763
K08 · FY2013 · DK · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$918
K08 · FY2013 · DK · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$153,763
K08 · FY2012 · DK · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$153,763
K08 · FY2011 · DK · contact PI
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk$153,763
K08 · FY2010 · DK · contact PI